Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose.
about
Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acidBalkan endemic nephropathy: an update on its aetiologyAn Integrated View of Aristolochic Acid Nephropathy: Update of the LiteratureExploiting the nephrotoxic effects of venom from the sea anemone, Phyllodiscus semoni, to create a hemolytic uremic syndrome model in the rat13C-NMR data of diterpenes isolated from Aristolochia Species.Response of Bone Resorption Markers to Aristolochia longa Intake by Algerian Breast Cancer Postmenopausal Women.Evaluating weight of evidence in the mystery of Balkan endemic nephropathy.Misdiagnosis and undiagnosis due to pattern similarity in Chinese medicine: a stochastic simulation study using pattern differentiation algorithm.Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouseBalkan endemic nephropathy-current status and future perspectives.Development of a chronic kidney disease model in C57BL/6 mice with relevance to human pathologyRisk assessment of upper tract urothelial carcinoma related to aristolochic acid.Combination of extracts from Aristolochia cymbifera with streptomycin as a potential antibacterial drugMicroarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells.Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid.Subchronic toxicity studies of the aqueous extract of Aristolochiae fructus in Sprague-Dawley rats.Influence and analysis of low-dosage steroid therapy in severe aristolochic acid nephropathy patients.Historical and modern medicinal plant uses--the example of the Ch'orti' Maya and Ladinos in Eastern Guatemala.A meta-analysis of medicinal plants to assess the evidence for toxicity.Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy.Aristolochic acid nephropathy: what we know and what we have to do.Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid.Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy.Assessment of the cytotoxicity and genotoxicity properties of Uvaria chamae P. Beauv (Annonaceae) and Morinda lucida Benth (Rubiaceae) in mice.Cytotoxicity of phenanthrenes extracted from Aristolochia contorta in human proximal tubular epithelial cell line.Acute kidney injury induced by aristolochic acid in patients with primary glomerular nephritis.Update of aristolochic acid nephropathy in Korea
P2860
Q27021933-A615DFA3-963A-4F8E-974C-0A2B9FB4AABAQ28079308-2128C5D7-78E7-48E4-ADF3-C0D7265455E6Q30238670-272DB636-5226-4A6B-AF52-C3256A48C460Q33402623-9D8FF0FC-914C-4F70-AC3C-B9B845F9DCC4Q33422844-F2822C86-4B3D-4287-876F-BAF76DA04719Q33616333-5D75CDC2-D836-4F60-B3F6-49474BAB57DAQ34353066-010EA6AA-2029-4853-9223-15D9CC8562B7Q34569809-AF588E44-6575-4FA1-A50C-9E4A961A96D3Q35057152-A6225040-BED3-46F1-AF80-F1CC93CD7755Q35452465-F42CDE5F-709B-45BE-8ADE-382613AD35E2Q36744185-9A841D44-2AC5-4A84-87B9-B78EA6A96C43Q36831822-60806B16-10D4-4724-AC71-8C4F72F36A91Q37165462-CCDC0D40-F86B-45DF-B144-68FE3B3079BEQ37728975-CA6C1E2D-224A-47B9-91E5-1E20F35CBFBEQ38154957-3680D361-48C8-42EA-94F0-FE70C0C83F92Q38508272-7A69B206-7123-4D7D-A026-ABF5FB8771F8Q40272039-0C7855F0-DFBF-445E-A45D-C44C081C7465Q40501029-F6F3ED93-A0E8-4EE2-8103-17474DB5661CQ41965328-496EAE82-9BD7-46E1-AE87-79B4B8718DACQ44405520-550BECF3-5FD9-4D8B-A131-825C08DAED6DQ44930516-FC1B333B-0C77-4489-BE77-98BDF012025AQ44930526-0298268C-AAC1-41DB-AAC6-26AEE72D762AQ45073529-E71404EC-E2F7-456D-BF77-AD6AD9A217E3Q46667114-4A0B1861-04FB-46BD-BF53-ED8BBA0A99C6Q47908482-D4BB1413-37BA-4634-A545-4B2EBBA1B92CQ53631058-20358ACC-76F7-4D0B-8436-C7D20C302241Q54429651-6F8FEB05-2E38-4413-8D79-041C0C10347BQ57213397-075B2E15-2A60-41B5-8A83-44F8A67E3AF1
P2860
Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Progression rate of Chinese he ...... olochia fangchi ingested dose.
@en
type
label
Progression rate of Chinese he ...... olochia fangchi ingested dose.
@en
prefLabel
Progression rate of Chinese he ...... olochia fangchi ingested dose.
@en
P2093
P356
P1476
Progression rate of Chinese he ...... olochia fangchi ingested dose.
@en
P2093
Jean-Louis Vanherweghem
Joëlle Nortier
Marie-Carmen Muniz Martinez
Pierre Vereerstraeten
P304
P356
10.1093/NDT/17.3.408
P407
P577
2002-03-01T00:00:00Z